JAK2 and idiopathic pulmonary fibrosis: Further implicating inhibition of tyrosine kinase as a therapeutic approach to oppose vascular contraction, JAK2 inhibitor JSI-124 induced artery relaxation in PCLS from patients with IPF, though in patients with PH secondary to IPF, the relaxant effect was significantly inhibited [29].